ACE Inhibitors and Mounjaro: How They Interact

Step 1: Understanding what each medicine is doing in your body

ACE inhibitors (medicines like ramipril, lisinopril and perindopril) work by blocking the angiotensin-converting enzyme, which relaxes blood vessels and reduces the workload on the heart. They are first-line treatments for high blood pressure, heart failure and chronic kidney disease.

Mounjaro is a dual GIP and GLP-1 receptor agonist, the only weight-loss medicine licensed in the UK that activates both gut-hormone pathways simultaneously. It slows gastric emptying, reduces appetite and helps regulate blood sugar. The tirzepatide overview covers its mechanism in more detail if you want the science.

Neither medicine directly targets the other's pathway. There is no pharmacokinetic interaction recorded between tirzepatide and ACE inhibitors in the prescribing information. What matters clinically is what both medicines do to blood pressure, kidney perfusion and fluid balance, and how those effects compound when they work at the same time.

This is why your medication history matters so much at the start. A prescriber who sees both medicines listed can set the right monitoring plan from day one, rather than responding to problems after the fact.

Step 2: The blood-pressure and kidney considerations your prescriber weighs up

Tirzepatide has a natriuretic effect, it encourages the kidneys to excrete sodium and water, which tends to lower blood pressure. ACE inhibitors do something similar through a different route. When both are active, the combined blood-pressure-lowering effect can be greater than either alone.

For most people this is fine, or even welcome. If your blood pressure was sitting slightly above target, both medicines working together may bring it down into a healthy range. But if your baseline pressure is already well controlled, or if you become dehydrated during the early weeks of Mounjaro treatment (nausea and reduced appetite can reduce fluid intake), blood pressure can fall further than intended.

There is also a kidney angle. ACE inhibitors are protective for the kidneys in most people, but they reduce filtration pressure slightly. Add dehydration, and kidney function can dip transiently. This is not a reason to avoid the combination, it is a reason for your prescriber to know about it and to advise you to stay well hydrated, especially in the first month. The full Mounjaro guide includes practical notes on managing the early adjustment period.

According to the NHS tirzepatide patient information, dizziness and low blood pressure are listed side effects that are worth reporting if they occur, more so when you are also on an antihypertensive.

Step 3: What sustained weight loss may mean for your ACE inhibitor dose

This is the part people often don't think about at the start. High blood pressure is frequently linked to excess weight. As tirzepatide works and body weight falls (sometimes by 15% or more over the course of treatment, as seen in the SURMOUNT-1 trial published in the New England Journal of Medicine) blood pressure commonly improves independently of any medicine.

Over months, some people find they need a lower dose of their ACE inhibitor, or occasionally no longer need it at all. That is a good outcome, and one that needs to be managed by a prescriber rather than decided unilaterally: stopping or reducing a blood-pressure medicine without a clinical review can be risky. If you are curious about how individual doses are structured, our guide to what 2ml of tirzepatide represents in practice explains how volume and dose relate across the treatment journey.

At nume, a real clinician reviews your progress before every repeat order, not a software check. If your blood-pressure readings are shifting, that is exactly the kind of change a prescriber should factor into your ongoing care. You can read more about how our clinical team approaches ongoing reviews on the clinical team page.

It is worth letting your GP know you are starting a weight-loss medicine. GP notification is part of how we work, in line with GPhC guidance. Your GP can monitor your blood pressure and kidney function in the ordinary course of care, which, alongside a noon dispatch window that fits around a working day, is part of what makes a properly supervised service different from an unmonitored one.

Side effects to be aware of when you are on both medicines

Both ACE inhibitors and Mounjaro individually list dizziness as a possible side effect. Together, the risk of postural hypotension (the brief drop in blood pressure when you stand up quickly) is worth being aware of, especially in the first few weeks. Staying hydrated and taking things slowly when you stand are sensible practical steps.

Mounjaro's common side effects are gastrointestinal: nausea, loose stools, constipation and reduced appetite are the ones most people notice at the start of treatment. Reduced appetite means reduced fluid intake for some people, which is the dehydration risk that intersects with ACE inhibitor use. Drinking enough water matters more than usual.

If you notice significant dizziness, swelling, a sharp reduction in urine output or any signs of a severe allergic reaction, seek medical help promptly. For a fuller picture of what the evidence says about Mounjaro's side-effect profile, facial changes during Mounjaro and other physical effects are covered in separate guides, including how weight loss can alter the appearance of your face over the course of treatment and what to do if you notice a rash developing on your face while using the medicine. You can also contact the aftercare team seven days a week if a question comes up between reviews.

Suspected side effects can be reported to the MHRA via the Yellow Card scheme, this applies to both medicines.

If you are considering Mounjaro and take an ACE inhibitor, a thorough clinical assessment is the natural starting point. Speak to our prescribers, the consultation is free, and your full medication list is reviewed before any prescription is issued.